Moberg Pharma announces issue of U.S. Patent for Kerasal

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Moberg Pharma announces issue of U.S. Patent for Kerasal Nail

STOCKHOLM, March 25, 2015. Moberg Pharma AB (OMX: MOB) today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 8,987,330 for Moberg Pharma’s market-leading product Kerasal Nail®, an over-the-counter (OTC) product for fungal nails. The patent expires in 2034. The new U.S. patent comprises composition of matter claims directed to novel formulations for topical application to the nails. Moberg Pharma is pursuing corresponding patent approval in all major territories. Based on this innovation, Moberg Pharma launched the second generation of its market leading product Kerasal Nail® in the U.S. last year in major drugstores including CVS, Walgreens and Rite-Aid, mass retailers including Walmart and Target and leading grocery chains including Publix and Safeway. Kerasal Nail is the leading product in the U.S OTC fungal nail category with 22% market share in 2014 according to IRI, and available at more than 30,000 outlets. The product is also sold in more than 30 countries worldwide through distributors. “The new Kerasal Nail patent provides long-term intellectual property protection for our flagship product in the U.S. It also reconfirms our commitment to bringing innovation to underserved niches and our long term goal to be the leading player in nail fungus,” said Peter Wolpert, CEO of Moberg Pharma AB. About Nail Fungus and Kerasal Nail® Approximately 10% of the general population suffers from onychomycosis (nail fungus) and a majority of those afflicted go untreated. Kerasal Nail® is a non -prescription product based on a novel formulation of proven compounds and is clinically proven to rapidly improve the appearance of unsightly fungal nails. Kerasal Nail is applied to the damaged nail using a no-mess, silicone tip applicator. Its efficacy and safety have been documented in several clinical trials including more than 600 patients. Kerasal Nail has a unique rapid mechanism of action and has demonstrated compelling treatment results, including visible improvement within 2-4 weeks. About this information Moberg Pharma discloses this information pursuant to the Swedish Securities Markets Act and/or the Financial Instruments Trading Act. The information was submitted for publication at 8.30 a.m. (CET) on March 25, 2015. For additional information contact: Peter Wolpert, CEO, Telephone: +46 (0)70 - 735 7135, E-mail: peter.wolpert@mobergpharma.se Kjell Rensfeldt, VP R&D, Telephone: +46 (0)70 – 712 4532, Email: kjell.rensfeldt@mobergpharma.se About Moberg Pharma Moberg Pharma AB (publ) is a rapidly growing Swedish pharmaceutical company with OTC sales operations in the U.S. and a distributor network in more than 40 countries. The company’s portfolio includes the OTC brands Kerasal®, Jointflex®, Kerasal Nail®, Domeboro®, Vanquish®, and Fergon®. Kerasal Nail® (Emtrix® or Nalox™ in certain ex-U.S. markets) is a leading OTC treatment of nail disorders in the U.S., Canada and several EU markets and is currently being launched in Southeast Asia. The company is growing organically as well as through acquisitions. Internal development programs focuses on innovative drug delivery of proven compounds and include two phase II assets, MOB-015 (onychomycosis) and BUPI (oral mucositis). Moberg Pharma has offices in Stockholm and New Jersey and the company’s shares are listed on the Small Cap list of the NASDAQ OMX Nordic Exchange Stockholm (OMX: MOB). For further information, please visit: www.mobergpharma.com.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CCAPP Holiday Training Targets Seasonal Recovery Strain

Updated Category News Views 72

December cheer has a nasty habit of hiding the people barely holding themselves together. CCAPP’s upcoming virtual workshop, Hope for the Holidays: Understanding Depression, Stress & Resilience During the Holiday Season, takes that uncomfortable reality seriously rather than treating it like a seasonal footnote. For behavioral health workers supporting people in...

Continue Reading
APEC's Shenzhen Signal Is Bigger Than a Two-Day Summit

Updated Category News Views 92

Shenzhen spent two days trying to turn regional anxiety into a workable agenda. The APEC CEO Summit 2026, held November 17 and 18 at the Qianhai International Convention Center, brought together more than 2,000 political and business leaders from all 21 APEC economies and 13 economies outside the group. That is a serious room, not a ceremonial photo line. Still, investors...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 81

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 65

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Jalisco’s Culinary Push Puts Tourism Strategy in Focus

Updated Category News Views 50

A destination sells itself twice: first with a memorable meal, then with a reason to come back. Jalisco’s stated effort to connect the world’s cuisines through The 50 Best Gastronomic Experiences belongs in that second category. It is not merely restaurant chatter. It reads as part of a broader attempt to make the state’s tourism offering feel deeper, more varied...

Continue Reading
Midterm Voters Put Cost Relief Ahead of Washington Wars

Updated Category News Views 78

Gas pumps and medical bills have a way of humiliating every grand political slogan ever printed. Seven Letter Insight's latest post-election survey says confirmed 2026 midterm voters want the 120th Congress to deal with costs first, particularly gas prices, health care, restoring health care tax credits and energy bills. That is not a glamorous mandate. It is, however,...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 15

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
S&P Global's December 8 Talk Puts Guidance in Focus

Updated Category News Views 71

A 35-minute fireside chat can be a whole lot of nothing, or it can leave a useful breadcrumb trail for shareholders willing to listen closely. S&P Global has put December 8, 2026 on the calendar, when Chief Executive Officer Martina Cheung is scheduled to appear at Goldman Sachs' 2026 Financial Services Conference in New York. Her slot runs from 5:00 p.m. to 5:35 p.m....

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 34

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
KidneyVoter Push Turns Patient Frustration Into Clout

Updated Category News Views 313

A ballot registration drive rarely tells the whole story, but it can reveal where the pressure is building. The American Association of Kidney Patients says its 2026 nonpartisan KidneyVoter™ effort, “50 States in 50 Days,” reached constituencies in every state after launching September 14. That does not produce a clean vote total or prove legislators will suddenly...

Continue Reading

Top 5 Most Recently Viewed Articles

Carvana's Stock Peaks at $187.37 Amid Renewed Investor Confidence

Updated Category News Views 79

Carvana's Impressive Stock Surge to 52-Week High Recently, Carvana Co (NYSE: CVNA) achieved a remarkable milestone by hitting a 52-week high of $187.37. This surge highlights a robust recovery for the online used car retailer, whose stock has skyrocketed by an impressive 377.82% over the past year. This surge in stock price signifies renewed investor confidence in...

Continue Reading
ABM Industries Closes Q3 with Strong Earnings and Growth Boost

Updated Category News Views 133

ABM Industries Reports Strong Q3 Earnings ABM Industries (NYSE: ABM) saw its share price jump nearly 7% following the announcement of its third quarter earnings, which exceeded analyst expectations and prompted an upgrade to its full-year guidance. This positive outcome underscores the company's resilience in a challenging market landscape. Robust Financial Performance In...

Continue Reading
Transforming Senior Care: Click Holdings Embraces Cryptocurrency

Updated Category News Views 144

Innovative Strategies in Senior Care by Click Holdings Limited Click Holdings Limited (NASDAQ: CLIK) is making headlines with its groundbreaking approach to enhancing senior care services. Based in Hong Kong, this company combines cutting-edge human resources solutions with innovative cryptocurrency strategies, aiming to redefine how care services operate in an evolving...

Continue Reading
Cypress Creek and Meta Join Forces for Major Solar Project

Updated Category News Views 360

Cypress Creek and Meta's Renewable Energy Partnership In an exciting development, Cypress Creek Renewables and Meta have reached a significant milestone through their new Environmental Attribute Purchase Agreement (EAPA). This agreement is set to pave the way for the construction of a massive 505MWdc solar facility named Hanson Solar. With a capacity of 396MWac, this...

Continue Reading
The Shipyard Sets Sail with San Diego Headquarters Expansion

Updated Category News Views 462

The Shipyard Sets Sail with San Diego Headquarters Expansion The Shipyard, one of the fastest-growing independent marketing agencies in the nation, has announced an exciting development. The agency is expanding its operations by opening a new headquarters located in downtown San Diego at 185 West F Street. This move signifies a deepening of their commitment to California,...

Continue Reading